MCM
RIGL icon

Munder Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Munder Capital Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$248K Sell
12,797
-1,091
-8% -$30.8K ﹤0.01% 551
2014
Q2 		$504K Sell
13,888
-489
-3% -$16.6K ﹤0.01% 513
2014
Q1 		$558K Buy
14,377
+914
+7% +$32.6K ﹤0.01% 509
2013
Q4 		$384K Hold
13,463
– – ﹤0.01% 538
2013
Q3 		$482K Buy
13,463
+6,800
+102% +$248K ﹤0.01% 511
2013
Q2 		$223K Buy
+6,663
New +$302K ﹤0.01% 545

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Munder Capital Management's RIGL Position: Q3 2014 in Review

Munder Capital Management reduced its Rigel Pharmaceuticals (RIGL) stake by 7.9% in Q3 2014, selling an estimated $30.8K and leaving 12,797 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #551.

Munder Capital Management first reported a position in RIGL in Q2 2013 and has held it in 6 quarters since. The position peaked at $558K in Q1 2014. 104 funds tracked by Wall St. Rank hold RIGL as of Q3 2014.

  • Munder Capital Management held 12,797 shares of Rigel Pharmaceuticals worth $248K as of Q3 2014.
  • Munder Capital Management sold 1,091 Rigel Pharmaceuticals shares in Q3 2014, an estimated $30.8K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Munder Capital Management's portfolio in Q3 2014, its #551 holding.
  • Munder Capital Management first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
  • Munder Capital Management's Rigel Pharmaceuticals position peaked at $558K in Q1 2014.
  • 104 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.